{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0016049",
      "entity_text" : "cell growth",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03695",
      "entity_text" : "IL3L",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Here we show that IL3L exosomes, loaded with Imatinib or with BCR-ABL siRNA, are able to target CML cells and inhibit in vitro and in vivo cancer cell growth.",
  "reading_complete" : "2020-08-03T13:27:20Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:25:58Z",
  "trigger" : "inhibit",
  "evidence" : [ "IL3L exosomes, loaded with Imatinib or with BCR-ABL siRNA, are able to target CML cells and inhibit in vitro and in vivo cancer cell growth" ],
  "pmc_id" : "5399597",
  "score" : 0
}